LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

Search

Globus Medical Inc (Class A)

Abierto

SectorSanidad

91.79 1.32

Resumen

Variación precio

24h

Actual

Mínimo

90.36

Máximo

91.75

Métricas clave

By Trading Economics

Ingresos

-84M

119M

Ventas

24M

769M

P/B

Media del Sector

28.508

110.024

BPA

1.18

Margen de beneficios

15.469

Empleados

5,300

EBITDA

22M

215M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+17.56% upside

Dividendos

By Dow Jones

Próximas Ganancias

24 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

3.6B

12B

Apertura anterior

90.47

Cierre anterior

91.79

Noticias sobre sentimiento de mercado

By Acuity

78%

22%

324 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Globus Medical Inc (Class A) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 feb 2026, 23:55 UTC

Charlas de Mercado

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 feb 2026, 23:53 UTC

Charlas de Mercado

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 feb 2026, 23:53 UTC

Charlas de Mercado

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 feb 2026, 23:51 UTC

Charlas de Mercado

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 feb 2026, 23:35 UTC

Charlas de Mercado

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 feb 2026, 23:21 UTC

Ganancias

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 feb 2026, 23:20 UTC

Ganancias

Nickel Industries 2025 Operating Profit US$126.4 Million

22 feb 2026, 23:19 UTC

Ganancias

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 feb 2026, 23:19 UTC

Ganancias

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 feb 2026, 23:18 UTC

Ganancias

Nickel Industries Won't Pay a Final Dividend

22 feb 2026, 23:16 UTC

Ganancias

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 feb 2026, 21:35 UTC

Ganancias

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 feb 2026, 21:34 UTC

Ganancias

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 feb 2026, 21:34 UTC

Ganancias

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 feb 2026, 21:33 UTC

Ganancias

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 feb 2026, 21:33 UTC

Ganancias

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 feb 2026, 21:28 UTC

Ganancias

Ampol Final Dividend A$0.60/Share

22 feb 2026, 21:28 UTC

Ganancias

Ampol FY Revenue A$31.37 Billion, Down 10%

22 feb 2026, 21:28 UTC

Ganancias

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 feb 2026, 21:28 UTC

Ganancias

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 feb 2026, 14:31 UTC

Adquisiciones, fusiones, absorciones

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 feb 2026, 05:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

20 feb 2026, 23:12 UTC

Adquisiciones, fusiones, absorciones

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 feb 2026, 22:12 UTC

Ganancias

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

20 feb 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

20 feb 2026, 21:23 UTC

Ganancias

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 feb 2026, 21:20 UTC

Charlas de Mercado

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 feb 2026, 21:01 UTC

Adquisiciones, fusiones, absorciones

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 feb 2026, 20:38 UTC

Charlas de Mercado

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Comparación entre iguales

Cambio de precio

Globus Medical Inc (Class A) previsión

Precio Objetivo

By TipRanks

17.56% repunte

Estimación a 12 Meses

Media 106.5 USD  17.56%

Máximo 118 USD

Mínimo 87 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Globus Medical Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

14 ratings

11

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

72.18 / 73.07Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

324 / 351 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat